BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26702852)

  • 1. Fatty liver disease and obesity in youth.
    Della Corte C; Mazzotta AR; Nobili V
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):66-71. PubMed ID: 26702852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease in Children.
    Mann JP; Valenti L; Scorletti E; Byrne CD; Nobili V
    Semin Liver Dis; 2018 Feb; 38(1):1-13. PubMed ID: 29471561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to Pediatric Obesity and Nonalcoholic Fatty Liver Disease.
    Ascher Bartlett JM; Mittal N
    Pediatr Ann; 2021 Nov; 50(11):e474-e477. PubMed ID: 34757877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.
    Lin CH; Kohli R
    Curr Gastroenterol Rep; 2020 Aug; 22(10):52. PubMed ID: 32814993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-alcoholic fatty liver disease in obese children and adolescents].
    Denzer C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):517-27. PubMed ID: 23529597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial Issues in Pediatric Nonalcoholic Fatty Liver Disease.
    Karaivazoglou K; Kalogeropoulou M; Assimakopoulos S; Triantos C
    Psychosomatics; 2019; 60(1):10-17. PubMed ID: 30318268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease and Fibrosis in Youth Taking Psychotropic Medications: Literature Review, Case Reports, and Management.
    Gracious BL; Bhatt R; Potter C
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):602-10. PubMed ID: 26447642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in Screening for Pediatric Nonalcoholic Fatty Liver Disease.
    Ferguson AE; Xanthakos SA; Siegel RM
    Clin Pediatr (Phila); 2018 May; 57(5):558-562. PubMed ID: 29022357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research advances in pediatric nonalcoholic fatty liver disease].
    Dai DL
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):107-12. PubMed ID: 25616307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".
    Fang YL; Chen H; Wang CL; Liang L
    World J Gastroenterol; 2018 Jul; 24(27):2974-2983. PubMed ID: 30038464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Non-alcoholic Fatty Liver Disease.
    Uppal V; Mansoor S; Furuya KN
    Curr Gastroenterol Rep; 2016 May; 18(5):24. PubMed ID: 27086005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.
    Marzuillo P; Grandone A; Perrone L; Miraglia Del Giudice E
    World J Gastroenterol; 2015 Jun; 21(21):6444-50. PubMed ID: 26074683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease.
    Panera N; Barbaro B; Della Corte C; Mosca A; Nobili V; Alisi A
    Nutr Res; 2018 Oct; 58():1-16. PubMed ID: 30340810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease].
    Drapkina OM; Deeva TA; Volkova NP; Ivashkin VT
    Ter Arkh; 2014; 86(10):116-23. PubMed ID: 25509904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet.
    FĂ©lix DR; Costenaro F; Gottschall CB; Coral GP
    BMC Pediatr; 2016 Nov; 16(1):187. PubMed ID: 27846831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Nobili V; Alkhouri N; Alisi A; Della Corte C; Fitzpatrick E; Raponi M; Dhawan A
    JAMA Pediatr; 2015 Feb; 169(2):170-6. PubMed ID: 25506780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease.
    Della Corte C; Liccardo D; Ferrari F; Alisi A; Nobili V
    Expert Opin Pharmacother; 2014 Dec; 15(17):2501-11. PubMed ID: 25219959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease in children and adolescents.
    Nobili V
    Clin Biochem; 2014 Jun; 47(9):720. PubMed ID: 24854694
    [No Abstract]   [Full Text] [Related]  

  • 19. Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment.
    Koot BG; van der Baan-Slootweg OH; Vinke S; Bohte AE; Tamminga-Smeulders CL; Jansen PL; Stoker J; Benninga MA
    Int J Obes (Lond); 2016 Jan; 40(1):51-7. PubMed ID: 26315844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.